Our Partners
Our current partners have invested time and resources in the development of GB-13. We are seeking additional partners in our pursuit to raise $6.7M to fund a Phase 1 clinical trial in brain cancer over the next two years.
Our current partners have invested time and resources in the development of GB-13. We are seeking additional partners in our pursuit to raise $6.7M to fund a Phase 1 clinical trial in brain cancer over the next two years.